Cardiff, United Kingdom

Claudia Nune

This inventor holds 1 USPTO granted patent. Top assignee: Cytiva Sweden Ab. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudia Nune. Retrieved from https://idiyas.com/inventor/claudia-nune

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudia Nune: Innovator in Cell Culture Technology

Introduction

Claudia Nune is a prominent inventor based in Cardiff, GB. She has made significant contributions to the field of cell culture technology, particularly in the development of methods that enhance the production of clinically relevant cell products. Her work is vital for advancements in cell therapy.

Latest Patents

Claudia holds 1 patent for her invention titled "Semi-static cell culture." This innovative patent focuses on cell culture in bioreactors, specifically flexible cellbag bioreactors. The invention aims to simplify the production processes for cell products that are crucial for therapeutic applications.

Career Highlights

Claudia is currently employed at Cytiva Sweden AB, where she continues to push the boundaries of biotechnological research. Her expertise in cell culture has positioned her as a key player in the industry, contributing to advancements that have the potential to improve patient outcomes.

Collaborations

Claudia collaborates with talented professionals such as Sarah Marie Stone and Lars Adamsson. These partnerships enhance her research and development efforts, fostering innovation in the field of cell therapy.

Conclusion

Claudia Nune's work in cell culture technology exemplifies the impact of innovative thinking in biomedicine. Her contributions are paving the way for future advancements in cell therapy, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…